MedTrace Logo

Randomizing Two Gestational Diabetes Screening Methods in a Diverse HMO

NCT02266758 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23792

Last updated 2023-08-02

No results posted yet for this study

Summary

This project randomizes two different screening strategies for diabetes in pregnancy, among a study population of over 17,500 pregnant women and their babies (over 35,000 total) in a large diverse health maintenance organization (HMO), to determine how diagnosis and treatment based on these two strategies in routine clinical care affects complications for the baby and the mother.

Conditions

  • Gestational Diabetes
  • Obesity
  • Pregnancy

Interventions

OTHER

GDM Screening Methods

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Teresa A Hillier, MD, MS · KP Center for Health Resarch, NW & Hawaii

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-03
Primary Completion
2018-12-31
Completion
2024-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02266758 on ClinicalTrials.gov